Article
Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival.
Annals of surgical oncology - 1 Oct 2020
Chen Ying, Tang Wen-Fang, Lin Huan, Bao Hua, Li Wei, Wang Ao, Wu Xue, Su Jian, Lin Jie-Shan, Shao Yang W, Yang Xue-Ning, Wu Yi-Long, Zhong Wen-Zhao
Abstract excerpt
BACKGROUND: This study aimed to evaluate the feasibility of a wait-and-see strategy for non-small cell lung cancer (NSCLC) patients with special pleural dissemination lesions (r-pM1a and s-pM1a). Furthermore, the study characterized genomic alternations about disease progression. METHODS: For this study, 131 NSCLC patients with a diagnosis of pM1a were retrospectively selected. Survival differences were evaluated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
